ライフサイエンスコーパス: borderline

1 unds transcending the Gram negative-positive borderline.

2 ed in the most influential manuscripts about Borderline.

3 esence of tubulitis, to reach a diagnosis of Borderline.

4 ent were dissatisfied with the definition of Borderline.

5 atients were still classified as LA and 9 as borderline.

6 A definite/borderline 2010 International Task Force Criteria arrhyt

7 We conducted a sensitivity analysis, using borderline abnormal image classifications.

8 years, identifying those with subclinical or borderline acute cellular rejection (ACR) at 3 months (A

9 There are also borderline amygdalar, claustral, and septal areas of the

10 eview confirmed 227 cases of latent RHD: 164 borderline and 63 definite (42 mild, 21 moderate/severe)

11 of epithelial ovarian cancer, including both borderline and invasive tumors.

12 component can be valuable in differentiating borderline and malignant ovarian epithelial tumours.

13 lue on the solid component, to differentiate borderline and malignant ovarian tumours.

14 nt (p = 0.001) of the mADC value between the borderline and malignant tumours.

15 However, it is difficult to distinguish the borderline and malignant tumours.

16 Children with both borderline and mild definite RHD are at substantial risk

17 asthma treatment adherence (2.54, 0.97-6.67-borderline), and anti-IgE use in a protective way (0.26,

18 68.9% (n = 379) were benign, 19.6% (n = 108) borderline, and 10.5% (n = 58) malignant.

19 ctive (CA) T cell-mediated rejection (TCMR), borderline, and antibody-mediated rejection (ABMR).

20 ed on histopathological examination: benign, borderline, and malignant.

21 There is considerable dissatisfaction with Borderline, and practice in Banff i thresholds is variab

22 -nine eyes (111 open, 78 narrow, including 8 borderline angles) were included.

23 gnificant associations were observed between borderline as well as high STC and periodontitis.

24 of age (OR range, 2.06-6.02; P </= .01) and borderline associated at 4 years of age (OR, 1.61 [95% C

25 it speed was associated with incident DM and borderline associated with incident CVD.

26 to the index date were excluded, there was a borderline association between any trauma and ALS (odds

27 A borderline association between family history of CD and

28 e final multivariable model (n=106) showed a borderline association between mild mesangial expansion

29 ta-analysis shorter RTL at baseline showed a borderline association with CKD progression (HR = 1.07 [

30 ociation with lower SPT response, as well as borderline association with low IgE reactivity to any al

31 otein B (gB) neutralizing epitope AD-2 had a borderline association with low risk of transmission (OR

32 Opisthorchiasis also showed borderline association with lower atopic symptoms.

33 eprocurement angiogram, donor age only had a borderline association with mortality (HR 1.20 [0.98-1.4

34 Borderline associations were seen among the presence of

35 a significant independent predictor of RNFL borderline attenuation or abnormal thinning in a logisti

36 ents with T cell-mediated rejection (Banff 3-Borderline, Banff 4-I/II/III), Banff-2 antibody-mediated

37 The definition of Banff Borderline became ambiguous when the Banff 2005 consensu

38 bnormal collagenous material deposits at the borderline between anterior and posterior layers of DM.

39 bnormal collagen inclusions, demarcating the borderline between both layers of DM.

40 edian age, 38 years); 7% of the nodules were borderline between HCA and hepatocellular carcinoma, and

41 s and is a useful tool for investigating the borderline between stable and unstable TM segments.

42 ues of the investigated solutions lie on the borderline between the values reported for sweet substan

43 tion, respectively.In clinical settings, the borderlines between INS and IF were not significantly di

44 res were classified as within normal limits, borderline (BL), and outside normal limits (ONL) on the

45 s per liter, multiply by 0.0259) and high or borderline BP were examined.

46 11.0% (95% CI, 8.8-13.4) had either high or borderline BP.

47 The two atypical proliferative (borderline) Brenner tumors both had RAS mutations.

48 us neoplasm, and two atypical proliferative (borderline) Brenner tumors was extracted from formalin-f

49 4 categories: normal, A; soft/hypotonic, B; borderline, C; and hypertonic, D.

50 ts undergoing loss or gain of methylation in borderline cases and could influence further clinical or

51 to successful selection endpoints means that borderline cases can be worked on with a high probabilit

52 utaneous anaplastic large cell lymphoma, and borderline cases.

53 to arbitrate disagreement among raters or in borderline cases.

54 rogeneity objectively identified occurred in borderline categories and higher ratio non-amplified cas

55 Among the 139 nephropathologists using the Borderline category, 67% use the Banff 1997 definition,

56 , histologic features of acute rejection and borderline changes that are associated with undesirable

57 ) blood samples and any rejection (including borderline changes) in 614 of 1763 (34.8%) blood samples

58 lassification, wherein 146 of 617 (23.7%) of borderline classifications became normal.

59 rion (abnormal = "outside normal limits" or "borderline" classifications).

60 ed tests and classified within the normal or borderline/clinical ranges using validated cutoffs.

61 t/hyperactivity disorder symptoms within the borderline/clinical ranges: odds ratio [OR] 0.97, 95% co

62 ologist, 1,616 were identified as containing borderline color results (negative result but with no pa

63 Borderline coronary lesions might become functionally si

64 se of dasatinib in CRPC bone metastases with borderline correlation with PFS.

65 prisons (such as through opt-out testing) is borderline cost-effective compared to status quo volunta

66 However, AF/AT was associated with a borderline decreased risk of mortality (hazard ratio, 0.

67 ving depression, and 32 patients (20.8%) had borderline depressive symptoms.

68 limitation of our study is the exclusion of borderline, difficult-to-classify lesions from our datas

69 ning (FS) depression in protocols 2 and 3, a borderline dysfunction in protocols 1 and 4, and had no

70 with reduced EF (LVEF <=40%), 42% in HF with borderline EF (LVEF, 41%-49%), and 31% in HF with preser

71 210 SD [95% CI -0.004 to 0.424] for T2 and a borderline effect of 0.216 SD [0.043 to 0.389] for T3) a

72 HF with reduced ejection fraction or HF with borderline ejection fraction (all P<0.05).

73 tion (HFpEF) (EF >/=50%), heart failure with borderline ejection fraction (HFbEF) (EF 41% to 49%), an

74 We also found borderline evidence of a statistical interaction between

75 d allele G of marker rs295340 (P = .042) and borderline evidence of an association between leprosy an

76 egarded as malignant and 10 were regarded as borderline following histopathological examination, the

77 nsity-weighted lifetime days (p = 0.049) and borderline for lifetime days (p = 0.073).

78 ficant for folate (P-trend = 0.007) and were borderline for thiamin (P-trend = 0.05).

79 stimate, 0.39+/-0.19% (SE)/decade; P=0.038), borderline greater global circumferential strain (adjust

80 m was analyzed in 220 HCAs, 373 HCCs, and 17 borderline HCA/HCC lesions.

81 g patients harboring early stage disease and borderline hepatic function.

82 Outcomes included HFpEF (EF>/=50%), borderline HFpEF (EF 40%-49%), HFrEF (EF<40%), and HF of

83 hazard ratio [HR], 1.21; 95% CI, 1.03-1.41), borderline HFpEF (HR, 1.37; 95% CI, 1.09-1.72), and HFrE

84 otal HF events (34.6% were HFpEF, 15.5% were borderline HFpEF, 37.1% were HFrEF, and 12.8% were HF of

85 ed with HIV have an increased risk of HFpEF, borderline HFpEF, and HFrEF compared with uninfected ind

86 ivariate models, all risk factors except for borderline high and high triglycerides in adolescence we

87 1999-2000 and 2011-2012, but either high or borderline high BP remained stable.

88 More than 90% of borderline high cholesterol patients are retested within

89 Patients with borderline high cholesterol typically progress to full h

90 ht (2.0 [1.4-2.9]), obesity (3.7 [2.0-7.0]), borderline high low-density lipoprotein cholesterol (1.6

91 ICC was borderline higher for private practice readers than for

92 3, 95% confidence interval, 1.15-1.31) and a borderline higher risk of major bleeding.

93 and stage (locally advanced vs resectable or borderline: HR, 1.66; 95% CI, 1.10-2.51, P = .016; metas

94 -2.51, P = .016; metastatic vs resectable or borderline: HR, 2.50; 95% CI, 1.64-3.79; P < .001) were

95 of a well-characterized cohort of untreated borderline hypertensive patients suggested that ARHGAP42

96 gh-normal triglycerides (100-149 mg/dL); (3) borderline hypertriglyceridemia triglycerides (150-199 m

97 All index cases had mild to borderline ID combined with behavioral problems consisti

98 tion; who have switched to the "healthy" or "borderline ill" severity categories; and the change in t

99 1 allergen in 8 of 10 (0.36-1.63 kUA/L) and borderline in 2 of 10 (0.21-0.25 kUA/L).

100 eveloped acute cellular rejection, which was borderline in one case.

101 is study aimed to explore and validate these borderlines in the clinical setting.Intestinal absorptio

102 As a result, recipients with tBKVN had borderline increased incidence for all urothelial cancer

103 A borderline increased prevalence of early-onset transient

104 Recent studies on the clinical impact of borderline infiltrates were also presented to clarify wh

105 l retinal degeneration with severe GCL loss, borderline inner nuclear layer thinning, and less promin

106 e an IQ score < 80, the clinical cut-off for borderline intellectual disability.

107 tains its efficacy in children with ADHD and borderline intellectual functioning or ID.

108 ith comorbid intellectual disability (ID) or borderline intellectual functioning.

109 ures using the short form of the Five-Factor Borderline Inventory.

110 ves without early enhancement and benign and borderline lesions as well as between the curves with ea

111 T cell-mediated rejection (Banff TCMR 1A and borderline lesions) remains unclear, due, in part to the

112 has occurred and DWV loads have remained at borderline levels of detection.

113 Prevalence of ideal and adverse (vs borderline) levels of lipids and apolipoprotein B per pe

114 identified tortuosity as the likely cause of borderline localized elevation in Doppler velocity.

115 lipoprotein cholesterol (1.6 [1.1-2.1]), and borderline low high-density lipoprotein cholesterol (1.4

116 imulating hormone levels were normal, with a borderline low level of testosterone (7.6 nmol/L; normal

117 lacement in young male cancer survivors with borderline low testosterone (7-12 nmol/l).

118 s for citrulline, methionine and lysine were borderline low, all attributed to the patient's special

119 Trabecular bone score was borderline lower (1.21 +/- 0.14 vs 1.3 +/- 0.15; adjuste

120 ng PH (69 patients with PH, 19 patients with borderline mPAP, and 57 patients with normal mPAP) who u

121 ll histological grades, including benign and borderline mucinous ovarian tumors, and compare these to

122 tients were classified into definite (n=38), borderline (n=39), or possible (n=43) ARVC.

123 11-5.41), psychic disorders (2.87, 0.89-9.30-borderline), nasal polyps (1.86, 0.88-3.89-borderline),

124 reas 18% of the children with fatty liver or borderline NASH developed definite NASH.

125 n with definite NASH compared to not NASH or borderline NASH in multivariable analysis (odds ratio =

126 Out of the patients with borderline NASH in the histologic NAS score, 48% were cl

127 alpha-diversity (control, 3.52; NAFLD, 3.36; borderline NASH, 3.37; NASH, 2.97; P = .001).

128 val have increased among infants born at the borderline of viability, but less is known about how inc

129 f misinterpretation or misapplication at the borderlines of suitability.

130 Those with borderline or abnormal GCC-FLV had a 4-fold increase in

131 s biopsies meeting criteria for CA TCMR plus borderline or acute TCMR.

132 Over a mean period of 1.6 +/- 0.4 years, borderline or definite NASH resolved in 29% of the child

133 The prevalence of borderline or definite rheumatic heart disease was 10.2

134 Eleven patients (58%) had borderline or increased portal vein minimum and maximum

135 e currently recommended only for patients at borderline or intermediate risk by the American College

136 If uncertainty remains for patients at borderline or intermediate risk, or if the patient is un

137 If uncertainty remains for patients at borderline or intermediate risk, or if the patient is un

138 ion of the mass, torsion or cyst rupture, or borderline or invasive malignancy confirmed surgically i

139 uming >/=200 mg/day were more likely to have borderline or lower IQ compared with children of mothers

140 and antisocial (OR, 1.4; 95% CI, 1.11-1.75), borderline (OR, 1.8; 95% CI, 1.41-2.24), and schizotypal

141 tly more abnormal in patients with possible, borderline, or definite ARVC compared with controls for

142 can be useful for classification as benign, borderline, or malignant because the malignant lesions a

143 Each case was classified as benign, borderline, or malignant.

144 s and glaucoma classification (i.e., normal, borderline, or outside normal limits) between scans with

145 Dissimilarly, serous borderline ovarian tumors (BOT) can progress into low-gr

146 PID was associated with an increased risk of borderline ovarian tumors, particularly among women who

147 ps of samples (epithelial ovarian carcinoma, borderline ovarian tumours, normal ovarian stroma) were

148 In 21 cases of borderline ovarian tumours, of which 11 were regarded as

149 tubular atrophy and inflammation (P = 0.04), borderline (P = 0.08), subclinical (P = 0.01) and clinic

150 0-borderline), nasal polyps (1.86, 0.88-3.89-borderline), partial/poor asthma treatment adherence (2.

151 Search terms were combined for borderline personality and randomized trials in PubMed,

152 tistic spectrum disorder, schizophrenia, and borderline personality and social anxiety disorders, may

153 nversion disorder (OR 3.3 [95% CI 2.2-4.8]), borderline personality disorder (2.9 [2.5-3.3]), anxiety

154 e interpersonal difficulties associated with borderline personality disorder (BPD) features in the do

155 Family and twin studies of Borderline Personality Disorder (BPD) have found familia

156 Borderline personality disorder (BPD) is a debilitating

157 Aggression in borderline personality disorder (BPD) is thought to be m

158 Extreme dysphoria is common in borderline personality disorder (BPD), especially when s

159 The psychological profile of patients with borderline personality disorder (BPD), with impulsivity

160 Although borderline personality disorder (BPD)-one of the most co

161 atening cues has been repeatedly observed in borderline personality disorder (BPD).

162 regulation of emotions are core symptoms of borderline personality disorder (BPD).

163 290 inpatients meeting rigorous criteria for borderline personality disorder and 72 axis II compariso

164 Quality was low for meta-analyses on borderline personality disorder and anxiety, and moderat

165 attitudes towards people with a diagnosis of borderline personality disorder and that this might impa

166 Taken together, the symptoms of borderline personality disorder are quite fluid, with re

167 nt use of antidepressants and a diagnosis of borderline personality disorder did not affect the respo

168 in the related conditions of antisocial and borderline personality disorder have produced preliminar

169 urrences that follow them, of 24 symptoms of borderline personality disorder over 16 years of prospec

170 the more clinically urgent acute symptoms of borderline personality disorder seem to have a better pr

171 utilation, help-seeking suicide attempts) of borderline personality disorder were more likely to remi

172 (mean age, 30.3 years; 69 [71%] white) with borderline personality disorder who had at least 2 suici

173 , followed by posttraumatic stress disorder, borderline personality disorder, and conversion disorder

174 Impulsive aggression and borderline personality disorder, but not psychopathy or

175 der, including depression, anxiety, bipolar, borderline personality disorder, schizophrenia, and auti

176 t or responses to people with a diagnosis of borderline personality disorder.

177 th nurses towards people with a diagnosis of borderline personality disorder.

178 ttitudes and without previous training about borderline personality disorder.

179 ps: (1) referent (</=18 mm Hg; n=4,207); (2) borderline PH (19-24 mm Hg; n=5,030); and (3) PH (>/=25

180 rd for hospitalization was also increased in borderline PH (HR=1.07; 95% CI, 1.01-1.12; P=0.0149) and

181 adjusted mortality hazard was increased for borderline PH (HR=1.23; 95% CI, 1.12-1.36; P<0.0001) and

182 The borderline PH cohort remained at increased risk for mort

183 ently associated with a higher likelihood of borderline PH compared with reference patients in a logi

184 To test the hypothesis that patients with borderline PH have decreased survival compared with pati

185 uum of risk according to mPAP level and that borderline PH is associated with increased mortality and

186 Borderline PH is common in patients undergoing RHC and i

187 % white) among whom the prevalence of PH and borderline PH was 62% and 18%, respectively.

188 ariates in a Cox proportional hazards model, borderline PH was associated with increased mortality co

189 In the 70 patients with borderline PH who underwent a repeated RHC, 43 (61%) had

190 least 25 mm Hg were classified as reference, borderline PH, and PH, respectively.

191 vert PH in patients initially diagnosed with borderline PH.

192 little is known about the natural history of borderline PH.

193 rt PH and to identify clinical correlates of borderline PH.

194 study the effect of treatment on outcome in borderline PH.

195 ease severity and associated with reduced or borderline plasma branched-chain amino acid (BCAA) conce

196 However, there were suggestions of borderline positive associations of the presence of any

197 ARVC diagnosis (categories: definite, borderline, possible) based on the 2010 Task Force Crite

198 atients were categorized into "definitive," "borderline," "possible," or "no" ARVC diagnostic groups

199 nts (10.1%) were downgraded from definite to borderline/possible disease at the time of initial genet

200 y demonstrate that MOC arise from benign and borderline precursors at the ovary and are not extra-ova

201 pports a progressive model of evolution from borderline precursors to high-grade invasive MOC.

202 ic effect was observed ( P = .61), whereas a borderline predictive effect ( P = .04) was observed wit

203 atients undergoing resection for PDAC, 40 LA/borderline received FOLFIRINOX and 87 received no neoadj

204 We observed a borderline recognition memory deficit by novel object re

205 tcomes in 79 patients diagnosed with TCMR 1A/borderline rejection across 11 US centers with a simulta

206 All rejections and clinical borderline rejections in protocol biopsies were treated.

207 Thirteen trials reported borderline-relevant outcomes at follow-up (g = 0.45; 95%

208 For borderline-relevant outcomes combined (symptoms, self-ha

209 Three patients in the contrast group had borderline renal function (estimated glomerular filtrati

210 erative factors can predict resectability of borderline resectable (BR) and locally advanced (LA) pan

211 lity, and survival outcomes in patients with borderline resectable (BR) or locally advanced (LA) panc

212 , 2006 and February, 2017, 280 patients with borderline resectable (n = 18), locally advanced (n = 19

213 t-naive patients aged 18 years or older with borderline resectable or locally advanced biopsy-proven

214 rative sequencing strategy for patients with borderline resectable or locally advanced pancreatic ade

215 Of 331 patients with borderline resectable or locally advanced PDAC, 30 achie

216 has not been shown to benefit patients with borderline resectable or locally advanced unresectable P

217 py did not improve survival in patients with borderline resectable or locally advanced unresectable P

218 bel, randomized (1:1) trial of patients with borderline resectable or locally advanced unresectable P

219 perative chemoradiotherapy for resectable or borderline resectable pancreatic cancer did not show a s

220 l in 16 centers, patients with resectable or borderline resectable pancreatic cancer were randomly as

221 the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall

222 ements support the preoperative treatment of borderline resectable pancreatic cancer, no prospective,

223 ant therapy is recommended for patients with borderline resectable PC and, at some centers, neoadjuva

224 and 65 had lower stage (48 resectable and 17 borderline resectable) tumors.

225 Of 274 included patients, 46.4% were borderline resectable, 25.5% locally advanced, and 83.2%

226 ries based on extent of disease: resectable, borderline resectable, locally advanced, and metastatic;

227 nts treated with neoadjuvant chemotherapy in borderline-resectable and locally advanced PDAC RESULTS:

228 patients with nonmetastatic, resectable, or borderline-resectable PBCs had a mean of 83.2 CTCs/7.5 m

229 ergoing upfront resection for resectable and borderline-resectable PDAC from 10/2001 to 12/2011 were

230 In the Phase II borderline-resectable trial (NCI# 01591733) cohort of 32

231 management options for regionally advanced, "borderline-resectable" MCC.

232 erapy is increasingly used in patients with (borderline-)resectable pancreatic cancer.

233 ic fistula after resection in patients with (borderline-)resectable pancreatic cancer.

234 Borderline resistant and heteroresistant phenotypes were

235 Borderline results (sensitivity, 99.6%; specificity, 89.

236 as 60.8% to 78.4% specific, depending on how borderline results were interpreted.

237 Children with mild definite and borderline RHD showed 26% and 9.8% echocardiographic pro

238 The proportion of cases borderline RHD who progressed to definite RHD was 11.3%

239 Of those with mild definite RHD or borderline RHD, more advanced disease category, younger

240 didate susceptibility gene for low-grade and borderline serous EOC.

241 s more prevalent in cases with no or minimal/borderline SHM.

242 or interstitial inflammation in diagnosis of borderline should be i0 or i1.

243 for physician-diagnosed rhinitis approaching borderline significance (AOR = 2.26; 95% CI: 0.88-5.83).

244 sitol binding clathrin assembly protein with borderline significance (change in risk = 0.165, 95% CI:

245 ed risk of mortality due to liver disease at borderline significance (P = 0.05).

246 The lowered risk of decompensation was of borderline significance among statin users with alcohol-

247 B (HR 1.4; 95% CI, 1.1 to 1.9) tumors, with borderline significance among women with triple-negative

248 Clearance <1.0 or <1.5 mm had borderline significance for the entire cohort, but was r

249 The EuroQol-5D quotient was of borderline significance in favor of therapy (-0.03; 95%

250 Of borderline significance is a decreased decompensation ra

251 pressure, carotid intima-media thickness and borderline significance with fasting insulin (p = 0.08).

252 RSS55-RP1L1, P(BONF) = 0.057) associated, at borderline significance, with BE/EA risk in female indiv

253 CagA+ vs CagA-), and this reduction reached borderline significance.

254 reatment and exclusive breastfeeding were of borderline significance.

255 ne only caused behavioral hyperactivity with borderline significance.

256 astfeeding on postweaning antibiotic use was borderline significant (estimated 4% decrease per month;

257 ratio, 6.08; p = 0.01), and hypokalemia was borderline significant (odds ratio, 3.23; p = 0.07).

258 h female breast cancer incidence, the former borderline significant (p = 0.050).

259 There was a borderline significant (p = 0.059) increasing trend with

260 ) and non-cardia (1.3-fold) cancers but were borderline significant for cardia cancers (1.1-fold).

261 ion AF/AT, and those randomized to CRT-D had borderline significant higher risk.

262 ng radiotherapy (p < 0.001), and there was a borderline significant increasing trend per treatment (p

263 ukin-6 and tumor necrosis factor-alpha and a borderline significant inverse correlation with interleu

264 However, there are borderline significant negative correlations (p = 0.08)

265 These differences were borderline significant when analyzed for the entire stud

266 ions was positive, while for masses this was borderline significant.

267 However, there was a borderline-significant increased risk with fingolimod, c

268 ssion, statin use (beta=-2.178; P=0.050) was borderline significantly associated with a reduced progr

269 hsCRP levels and lower sCD163 levels and was borderline significantly associated with higher sCD14 an

270 est (median: 556 mg/d) was associated with a borderline significantly lower risk of early menopause (

271 agnosis of atypical DIPG was associated with borderline significantly prolonged progression-free surv

272 women and men combined, total fat intake was borderline-significantly positively associated with NHL

273 to distant metastasis in GC patients with a borderline statistical significance (p = 0.0549).

274 s were associated with GOCD but were of only borderline statistical significance in a fully adjusted

275 akes of total protein and animal protein had borderline statistically significant associations with i

276 03, 1.33), which was primarily attributed to borderline statistically significant higher risk of CVD-

277 peak at 13.75 ppm, which is consistent with borderline-strong hydrogen bonds.

278 psychodynamic approaches, are effective for borderline symptoms and related problems.

279 sing all outcomes reported in the trials for borderline symptoms, self-harm, suicide, health service

280 ification and to risk stratify patients with borderline/TCMR 1A identified on biopsy.

281 The inner nuclear layer was normal or had borderline thinning.

282 ering IBBR and when indications for PMRT are borderline to enable informed decision-making regarding

283 Intellectual disability ranged from borderline to profound.

284 Skin biopsy was consistent with borderline tuberculoid leprosy with type 1 lepra reactio

285 l fibrosis and tubular atrophy, n = 52), and borderline tubulitis (3.3, [1.3, 4.9], n = 36).

286 one patient had a cystadenofibroma (partial borderline tumor), one patient had an androgenic ovarian

287 PID was associated with an increased risk of borderline tumors (pooled odds ratio (pOR) = 1.32, 95% c

288 isodes of PID had a 2-fold increased risk of borderline tumors (pOR = 2.14, 95% CI: 1.08, 4.24).

289 ectable in the cyst fluids of 19 of 23 (83%) borderline tumors, 10 of 13 (77%) type I cancers, and 18

290 women with ovarian cancers, 2,354 women with borderline tumors, and 14,736 control participants.

291 0.4% (95% CI 0.1-0.6), 0.3% (<0.1-0.5) for a borderline tumour, 0.4% (0.1-0.7) for torsion, and 0.2%

292 icipants with STC between 200 and 239 mg/dL (borderline) were 1.67 times (95% confidence interval [CI

293 and soluble cluster of differentiation-163 (borderline), were associated with higher QTVI and partia

294 Aflibercept-treated eyes, which had borderline worse vision and thicker maculae at baseline,

295 logy with AUROC of 0.89 (95% CI, 0.82-0.95), borderline zone 1 NASH with AUROC of 0.91 (95% CI, 0.83-

296 % of the children had definite NASH, 34% had borderline zone 1 NASH, 13% had borderline zone 3 NASH,

297 in (1) liver histology primary outcome, (2) borderline zone 1 NASH, and (3) fibrosis.

298 For borderline zone 1 NASH, the model (P = 0.0004) retained

299 There were 46 participants with borderline zone 1 nonalcoholic steatohepatitis (NASH) at

300 ASH, 34% had borderline zone 1 NASH, 13% had borderline zone 3 NASH, and 21% had fatty liver but not